TB The BioCentury Show

Podcast

The BioCentury Show

Tune in to BioCentury’s in-depth conversations with global leaders who are advancing the future of medicine.Join our Senior Editors in face-to-face discussions with scientific KOLs, top executives, VCs, and key policymakers, dissecting the most urgent public health issues.The BioCentury Show is THE only place where BioCentury’s experts join top innovators and global influencers to show how science is being turned into medicine.Don't miss this event, every two weeks, now available as a video webcast or audio podcast.

Website ↗ Last published 30 October 2026 75 posts collected by Sputnik

Said on The BioCentury Show

“We're weird, right, in our industry. Which other industry does not involve the end user in the development process? Whenever I speak to friends outside of our industry, they look at me as if I'm crazy. … What we're talking about here is different. It's really considering the patient perspective as an integral part of your development strategy and asking their views at the earliest stages of development, so you can incorporate it in your development plan, in your regulatory strategy, in your commercialization.” — Joep Muijrers, The BioCentury Show
Joep Muijrers · 30 Oct 2026 Listen →
“The good thing about small molecules is they go everywhere. The bad things about small molecules is they go everywhere, right? … They almost always do what you want them to do, but they'll do 19 other things.” — Chris Anzalone, The BioCentury Show
Chris Anzalone · 17 Oct 2026 Listen →

Hosts

The BioCentury Show is hosted by Simone Fishburn , Steve Usdin , Stephen Hansen , Selina Koch , Jeff Cranmer , Lindsay Martin and Tierney Baum .

Recent Episodes

  1. 30 Oct 2026

    Ep. 123 - Gilde’s Joep Muijrers on why patients belong in the investment process

    With Joep Muijrers

  2. 21 Oct 2026

    Ep. 122 - Tigermed's Britney Winterberger's take on running trials in the U.S. and China

    With Britney Winterberger

  3. 17 Oct 2026

    Ep. 121 - Arrowhead’s Chris Anzalone on the future of RNAi

    With Chris Anzalone

  4. 2 Oct 2026

    Ep. 120 - Canaan’s Julie Grant on building biotechs in white spaces

    With Julie Grant

  5. 18 Sep 2026

    Ep. 119 - Blackstone's Galakatos on funding biotech's hardest mile

    With Nick Galakatos

  6. 4 Sep 2026

    Ep. 118 - Regeneron's Gonçalo Abecasis on turning genetic data into drug targets

    With Gonçalo Abecasis

  7. 21 Aug 2026

    Ep. 117 - C-Path's Klaus Romero on moving genetic medicines beyond one patient

    With Klaus Romero

  8. 7 Aug 2026

    Ep. 116 - Ovid's Jeremy Levin on biotech in the balance

    With Jeremy Levin

  9. 23 Jul 2026

    Ep. 115 - Initiate's Owens on what it takes to be AI-native

    With Jessica Owens

  10. 10 Jul 2026

    Ep. 114 - Roivant’s Matt Gline on commercial launches and the future of the vant model

    With Matt Gline

  11. 25 Jun 2026

    Ep. 113 - Frank Jiang on Hengrui’s rise and China’s new era of biopharma dealmaking

    With Frank Jiang

  12. 18 Jun 2026

    Ep. 112 - Chris Arendt on rebuilding Takeda for AI

    With Chris Arendt

Guests

Bob Nelsen (2 episodes), David Altshuler (2 episodes), Craig Burton , Richard Pazdur , Jessica Owens , Karen Wagner , Chris Anzalone , Jeremy Bender , Zahid Moneer , Robert Plenge , Adam Koppel , John Maraganore , and 59 more.